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Abstract: Heinz bodies are intraerythrocytic inclusions of hemichrome formed as a result 
of hemoglobin (Hb) oxidation. They typically develop in aged red cells. Based on the 
hypothesis that hemichrome formation is an innate characteristic of physiologically normal 
Hb molecules, we present an overview of our previous findings regarding the molecular 
instability of Hb and the formation of hemichrome, as well as recent findings on Heinz 
body formation within normal human erythrocytes. Human adult Hb (HbO2 A) prepared 
from  healthy  donors  showed  a  tendency  to  produce  hemichrome,  even  at  close  to 
physiological temperature and pH. Recent studies found that the number of Heinz bodies 
formed  in  red  cells  increased  with  increasing  temperature  when  freshly  drawn  venous 
blood from healthy donors was subjected to mild heating above 37 ° C. These findings 
suggest that Hb molecules control the removal of non-functional erythrocytes from the 
circulation  via  hemichrome  formation  and  subsequent  Heinz  body  clustering.  In  this 
review, we discuss the molecular biosensing mechanisms in the spleen, where hemichrome 
formation and subsequent Heinz body clustering within erythrocytes play a key role in the 
removal of aged and damaged red cells from the blood circulation. 
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Abbreviations  
G-6-PD  glucose 6-phosphate dehydrogenase;  
Hb    hemoglobin;  
Mb    myoglobin;  
NADH   nicotinamide adenine dinucleotide, reduced form;  
MES    2-(N-morpholino) ethanesulfonic acid monohydrate. 
1. Introduction 
Human red blood corpuscles survive in the circulation for an average of 120 days. Removal of aged 
and damaged red cells from the blood circulation is essential for its homeostasis. Heinz bodies are 
intraerythrocytic inclusions of hemichrome formed from oxidized or denatured hemoglobin (Hb), and 
are typically formed in aged red cells. However, they have also been found and characterized in drug-
induced hemolytic anemia, defects in the intraerythrocytic reducing system (e.g., glucose 6-phosphate 
dehydrogenase [G-6-PD] deficiency) and in unstable Hb disease [1,2]. Heinz bodies have rarely been 
mentioned in the context of normal Hb or normal erythrocytes.  However, Heinz bodies in normal 
erythrocytes are of interest, because they, or their related intraerythrocytic inclusions, are involved in 
the recognition mechanisms in the spleen responsible for the removal of non-functional erythrocytes 
from the circulation. The rigid intraerythrocytic hemichrome inclusions are known to act as “sticking 
points”, and hence Heinz body-containing red cells become trapped and undergo hemolysis [3]. 
Hemichrome is rarely found in erythrocytes in situ, even though the reaction dynamics of Hb with 
molecular oxygen (O2) make it a particularly suitable O2 carrier. Hb can bind O2 in ferrous form to 
carry out its physiological functions. During this reversible O2 binding, the oxygenated form of Hb 
(HbO2) is known to be oxidized by the bound oxygen to the ferric met form (metHb), which cannot be 
oxygenated, and is thus physiologically inactive. Although metHb is reduced back to the ferrous state 
by an intraerythrocytic nicotinamide adenine dinucleotide (NADH)-dependent reducing system, it has 
been suggested that its  oxidation  (autoxidation) process  can be followed by transformation of the 
oxidized molecule (high-spin Fe
3+) into a species absorbing as a low-spin compound, i.e., hemichrome, 
the formation  of which can result in  the accumulation  of soluble and insoluble hemichromes and 
precipitation  [4-9].  Despite  these  findings,  direct  evidence  of  hemichrome  formation  in  normal 
erythrocytes is lacking. 
Hemichrome formation  is enhanced in separated α and β chains,  compared with the tetrameric 
parent Hb [5,9-12]. Following the method of Brunori et al. [10], our previous spectroscopic study [13] 
showed  that  human  adult  Hb  (HbO2  A)  from  healthy  donors  tended  to  degrade  to  produce 
hemichrome,  even  at  close  to  physiological  temperatures  and  pH.  However,  its  occurrence  was  a 
function of pH, temperature and progress of autoxidation of ferrous HbO2 A to the ferric met form, 
through oxidation by bound oxygen. Sensors 2010, 10                                       
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Based on the hypothesis that the instability of oxidized Hb that leads to hemichrome formation is 
not only a peculiarity of labile Hb in patients, but is also an innate characteristic of physiologically 
normal Hb molecules, the present review examines our previous findings on the molecular instability 
of Hb and its degradation to hemichrome, as well as the recent findings on Heinz body formation 
within normal human erythrocytes. The latter study [14] investigated the possibility of Heinz body 
formation  occurring  during  mild  heating  of  blood  samples  in  vitro,  at  close  to  physiological 
temperatures. The changes in normal human red blood corpuscles during mild heating were examined 
by light microscopy under oil-immersion. The number of Heinz bodies formed in red cells increased 
with increasing temperature. These observations, combined with the results of our previous study, 
suggest that Hb molecules control the removal of non-functional erythrocytes from the circulation 
through hemichrome formation and subsequent Heinz body clustering. In this overview, we examine 
the molecular biosensing mechanisms in the spleen responsible for the removal of aged and damaged 
red cells from the blood circulation. 
2. Innate Instability of Hb Molecule and Degradation to Hemichrome 
In this section, we discuss the results of our previous spectrophotometric study of hemichrome 
formation from human HbO2 A, in 0.1 M buffer at various temperatures and pH values [13]. HbO2 A 
was  prepared  from  freshly  drawn  human  blood  samples  (total  50–80  mL)  obtained  from  healthy 
donors. Samples were centrifuged at 2,400 g for 10 min to remove supernatant plasma and buffy coats. 
The erythrocytes obtained were washed five times with ice-cooled 0.9% NaCl solution (saline) by 
centrifugation  and  hemolysed  by  adding  the  same  volume  of  ice-cooled  distilled  water.  The 
hemolysate was then fractionated with ammonium sulfate between 20% and 70% saturation at pH 6.8. 
After dialysis, this solution was passed through two Sephadex G-50 columns (5 ×  90 cm) equilibrated 
with  10  mM  Tris-HCl  (pH  8.6).  The  effluent  Hb  fraction  was  further  separated  using  a 
diethylaminoethyl-cellulose column (3 ×  15 cm) equilibrated with  10  mM  Tris-HCl (pH 8.6) and 
washed sequentially with stepwisely changing the buffer solutions as follows: (1) 60 mM Tris-HCl 
(pH 8.0); (2) 100 mM Tris-HCl (pH 7.5); finally (3) 100 mM NaCl with 100 mM Tris-HCl (pH 8.0). 
HbO2  A  was  eluted  out  as  the  major  fraction  with  60  mM  Tris-HCl  (pH  8.0)  and  used  in  the 
experiments after dialyzing against 5 mM Tris-HCl buffer (pH 8.5). 
Hemichrome formation was observed spectroscopically in 0.1 M buffer over wide pH (4.5–10.5) 
and temperature ranges (35–55° C). Two milliliters of solution containing 0.2 M buffer was placed in a 
test tube and incubated in a water bath maintained at each desired temperature (±  0.1° C) using a 
NESLAB  temperature  control  (Model  RTE-100  or  111  or  210;  NESLAB  Instruments,  Inc., 
Portsmouth, NH, USA). The reaction was started by adding the same volume of fresh HbO2 A solution 
(125–235  μM  in  heme  contents).  For  spectrophotometry,  the  reaction  mixture  was  then  quickly 
transferred  to  a  spectrophotometric  cell  (Spectrocell,  Type  Inject-A-Cell;  Funakoshi  Co.,  Tokyo, 
Japan) with a screw-cap-stopper, and changes in absorption at 450–650 nm were recorded on the same 
chart at measured time intervals. Spectra were recorded using a UV/VIS spectrophotometer (JASCO,  
Model  Ubest-50  or  V-560  or  V-570;  Japan  Spectroscopic  Co.,  Tokyo,  Japan),  equipped  with  a 
thermostatically controlled (within ±  0.1 ° C) cell holder. At the final state of each run, Hb molecules 
were  all  completely  converted  to  the  ferric  met  form  by  the  addition  of  potassium  ferricyanide.  Sensors 2010, 10                                       
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The buffers used were: acetate for pH 4.5–5.5, 2-(N-morpholino) ethanesulfonic acid monohydrate 
(MES)  for  pH  5.0–6.75,  N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic  acid  for  pH  6.55–8.3,  
2-(cyclohexylamino) ethanesulfonic acid for pH 8.2–10.2, and 3-cyclohexylaminopropanesulfonic acid 
for pH 10.0–10.5. 
Figure 1 shows some examples of spectrophotometric changes in hemichrome formation during 
autoxidation of HbO2 A; its occurrence is inseparably related to the autoxidation process. HbO2 A can 
be oxidized to its ferric met form through the tendency of the bound dioxygen to oxidize ferrous heme 
iron (II), with generation of superoxide anions, as shown by the following reaction: 
Hb(II)O2              metHb(III) + 4(O2 
-)  
where kA represents the observed rate constant of the autoxidation at a given pH and temperature. As 
shown  in  Figure  1a,  the  observed  spectra  proceeded  with  time  with  no  evidence  of  hemichrome 
formation during the entire process when fresh HbO2 A was placed in 0.1 M MES buffer (pH 5.0)  
at 37 ° C. However, when HbO2 was incubated in 0.1 M MES buffer (pH 6.5) at 40 °C , the situation 
was  very  different  (Figure  1b).  During  the  late  stage  of  autoxidation,  a  sudden  disruption  of  the 
recorded  spectra  was  observed;  autoxidation  was  occurring,  but  hemichrome  formation  could  be 
detected by an elevation of the base line and a shift of the isosbestic points, caused by precipitation. 
Hemichrome formation during autoxidation was examined spectrophotometrically while varying the 
temperature of the solution from 35 °C  to 55 °C  and the pH from 4.5 to 10.5. Hemichrome formation 
could be observed at every stage during the course of autoxidation, i.e., during the initial, intermediate, 
and  final  stages,  as  a  function  of  pH  and  temperature  of  the  solution.  A  diagram  illustrating  the 
phenomenon is depicted in Figure 2. 
The phenomenon was not simple, and its occurrence was a function of not only pH and temperature 
of  the  solution,  but  also  of  the  progress  of  autoxidation  of  HbO2 A.  We  therefore  attempted  to 
categorize the phenomenon into the following four cases in terms of [HbO2] t= E.P. /[HbO2] 0: 
(1) t = 0 or [HbO2] t= E.P. /[HbO2] 0 = 1 ≤ t E.P. < [HbO2] t= E.P. /[HbO2] 0 = 0.75; 
(2) [HbO2] t= E.P. /[HbO2] 0 = 0.75 ≤ t E.P < [HbO2] t= E.P. /[HbO2] 0 = 0.25; 
(3) t E.P. ≤ [HbO2] t= E.P. /[HbO2] 0 = 0.25; 
(4) no hemichrome formation during the entire process. 
E.P. is the observed emergence point of hemichrome formation in each run. [HbO2] t= E.P. /[HbO2] 0 is 
the ratio of HbO2 concentration after time t = E.P. to that at time t = 0 and can be monitored by the 
absorbance  ratio  of  (At  -  A∞)/(A0  -  A∞)  at  576  nm  (α-peak  of  HbO2  A).  Since  [HbO2]  t=  E.P.  
/[HbO2] 0 = 0.5 represents equal mixtures of HbO2 and metHb, i.e., the midpoint of the autoxidation 
reaction, case 1 means that hemichrome formation was noticeable at the initial stage of autoxidation. 
Accordingly, case 2 indicates its occurrence at the intermediate stage, and case 3 at the final stage. In 
Figure 2, the symbols used correspond to:  for case 1,  for case 2,  for case 3 and  for case 4, 
respectively.  To  determine  if  the  phenomenon  was  represented  by  case  3  or  case  4,  the  reaction 
mixture was converted to metHb by the addition of small amounts of ferricyanide and maintained at 
the given temperature for 2 days to see whether hemichrome precipitation occurred. 
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Figure 1. Spectral changes over time associated with hemichrome formation for human 
HbO2 A redrawn from Sugawara et al. [13]. (a) Monitoring in 0.1 M MES buffer (pH 5.0) 
at 37 °C  and (b) in 0.1 M MES buffer (pH 6.5) at 40 °C . In case a, hemichrome formation 
was not detected until the reaction was almost 75% complete. In case b, the emergence of 
hemichrome due to accumulation and precipitation of soluble and insoluble hemichromes 
was noticeable by sudden disruption of the recorded spectrum at the final stage (at around 
17.5  h)  of  the  time  course.  Conditions:  HbO2  concentration  was  235  μM  (in  heme 
contents); and scanning intervals were (a) 15 min and (b) 150 min. 
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Figure 2. pH-temperature diagram of hemichrome formation for human HbO2 A, redrawn 
from Sugawara et al. [13]. The symbols represent: - hemichrome formation noticeable at 
initial stage during the course of autoxidation; - at intermediate stage; - at final stage; 
- autoxidation reaction proceeded with no hemichrome formation during the entire process. 
 
 
Thus, the findings shown in Figure 2 suggest that HbO2 A was highly susceptible to hemichrome 
formation, even under physiological temperature and pH. In Figure 2, solid lines show the threshold 
for this susceptibility in relation to pH and temperature. When compared with the tetrameric parent Hb 
molecules, the isolated α and β chains were found to have much higher susceptibilities to hemichrome 
formation, and showed individual pH-temperature diagrams [13]. Even though hemichrome formation 
is a function of pH, temperature, and progress of autoxidation, the phenomenon can be described in 
air-saturated conditions as: 
Hb(II)O2                metHb(III) + 4(O2 
-) → hemichrome 
As described elsewhere [13,15], electron paramagnetic resonance measurements were carried out 
for the resulting oxidation products of isolated β chains over a magnetic field of 0–500 mT at 8.0 K in 
10 mM maleate buffer (pH 6.2) and in the presence of 50% (v/v) glycerol. They demonstrated a  
low-spin spectrum with g values of g 1 = 2.77, g  2 = 2.27, and g 3 = 1.68, in addition to the usual  
aquo-met  species  with  g  values  of  5.86  and  1.99.  According  to  Rifkind  et  al. [9],  such  low-spin 
complexes characterized by the highest g values in the range of 2.83–2.75 and the lowest g values in 
the range of 1.69–1.63 have been designated as complex B, indicating the crystal field parameters of 
the reversible hemichrome, namely a water-retained bis-histidine complex. The molar fraction of the 
hemichrome (complex B) in the oxidized β chains was estimated to be 85% at pH 6.2, as a low-spin 
species was in equilibrium with a high-spin species corresponding to the usual aquo-met species. 
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3. Innate Instability of Hb Molecule, its Degradation to Hemichrome, and Subsequent Heinz 
Body Formation in Normal Human Erythrocytes during Mild Heating 
In this section, we discuss the results of our study investigating Heinz body formation in normal 
human erythrocytes [14]. Aliquots of freshly drawn venous blood from healthy donors were subjected 
to mild heating at temperatures above 37 ° C for 30 min, to investigate hemichrome formation and 
subsequent Heinz body formation in normal human erythrocytes. Heinz bodies were visualized by 
exposing blood smears to acetylphenylhydrazine and stained with crystal violet. Changes within the 
erythrocytes  were  observed  using  light  microscopy  under  oil-immersion.  Prior  to  the  Heinz  body 
formation test (acetylphenylhydrazine test) [16,17], the blood samples were subjected to mild heating 
in vitro. A 2-mL sample was placed in a test tube and incubated in a water bath maintained at each 
desired temperature (± 0.1 °C ) above 37 ° C for 30 min, using NESLAB temperature control (Model 
RTE-100 or 111 or 210 or 221). 
-Acetylphenylhydrazine and crystal violet (research grade for pathology) were used (Wako Pure 
Chemical, Co., Osaka, Japan) for the procedure, as described by Bauer [17]. A 0.1-mL aliquot of the 
blood  sample  was  suspended  in  2  mL  of  acetylphenylhydrazine  solution,  in  which  100  mg  of 
acetylphenylhydrazine and 200 mg of glucose in 100 mL of 0.067 M phosphate buffer were dissolved 
at pH 7.6. Using a “blowout” pipette, the solution was aerated two or three times by drawing it up into 
the pipette and blowing it out,  together  with  a small quantity of air.  This  mixture was  incubated  
at 37 °C  for 2 h. Aeration was repeated halfway through and immediately after the 2 h incubation. A 
drop (approximately 10 μL) of the resulting mixture was placed on a cover glass, which was then 
inverted onto a microscope slide containing 30 μL of crystal violet solution. The smear was allowed to 
stand for 20 min in wet preparation at room temperature and subsequently examined under a light 
microscope (Nikon Model-FXA; Nikon Co., Tokyo, Japan) equipped with a digital camera (Olympus 
Model-DP-70;  Olympus  Co.,  Tokyo,  Japan).  Photomicrographs  were  taken  under  oil-immersion  
at 1,000 ×  magnification. Subsequently, the number of Heinz bodies per cell was counted in 100 red 
cells per view. 
Figure 3 shows representative images of Heinz bodies within normal red corpuscles obtained from a 
healthy donor during mild heating to a given temperature. The blood sample used as a temperature-
untreated reference was kept at a low temperature (0–4 ° C) for as long as possible after withdrawal, 
and never exposed to  temperatures  above room temperature. Heinz bodies were observed in  each 
smear. Some of the changes are shown in Figure 4a; histograms of samples treated at 37 ° C and 42 ° C 
are displayed with a temperature-untreated sample as a reference, based on the number of Heinz bodies 
contained  in  each  of  100  red  cells  per  view.  These  results  confirmed  that  Heinz  body  formation 
increased with increasing temperature of the blood samples over 37 °C . Red cells in blood samples 
exposed to 48 ° C were hemolyzed. 
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Figure 3. Microscopic views of Heinz bodies after mild heating of blood samples obtained 
from one healthy donor, redrawn from Sugawara et al. [14]. Using a temperature-untreated 
sample as a control, aliquots of freshly drawn venous blood were subjected to mild heating 
at 37 ° C, 40 ° C, 42 ° C, 45 ° C or 48 ° C for 30 min. Heinz bodies were then visualized by 
exposure  to  acetylphenylhydrazine  and  dyeing  with  crystal  violet.  The  changes  that 
occurred within erythrocytes were observed by light microscopy under oil-immersion. 
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Figure 4. Histograms represent Heinz bodies detected in blood samples after mild heating  
above 37 ° C, redrawn from Sugawara et al. [14]. The histograms for 37 ° C and 42 ° C are 
displayed using a temperature-untreated sample as a reference. One hundred red cells were 
chosen and the number of Heinz bodies contained in each red cell was counted. Figure 4a 
was constructed from the microscopic views shown in Figure 3. 
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Figure 5. Histograms obtained from the arithmetic summation of all histograms shown in 
Figure 4, redrawn from Sugawara et al. [14]. The solid lines show the computed curve 
obtained  by  the  least-squares  method  using  a  Gaussian  curve.  The  resulting  Gaussian 
constants are summarized in the text. 
 
 
The other histograms shown in Figure 4 represent the results from another five healthy donors, with 
a  temperature-untreated  sample  as  a  reference.  Although  there  was  considerable  inter-individual 
variation, temperature-dependent Heinz body formation was apparent in all preparations. Arithmetic 
summation was used for all the histograms to reduce the variability and allow a better assessment of 
temperature-dependent Heinz body formation. The results of this summation are shown in Figure 5. 
Solid lines represent the curves derived using the least-squares method using a Gaussian curve. Each 
computed curve showed satisfactory-to-good agreement with the experimental data over the entire 
range. The following is a summary of the Gaussian constants resulting from the least-squares fitting: a 
(peak height) = 101, b (peak width at half of maximum) = 5.0 and c (peak location) = 4.0 for blood 
samples treated at 42 ° C; a = 215, b = 3.5 and c = 1.0 for blood samples treated at 37° C; and a = 215,  
b = 3.0 and c = 0.8 for temperature-untreated blood samples. 
4. In vitro Evaluation of Blood Fluidity during Mild Heating Using a Micro-channel Array Flow 
Analyzer to Give an Index of Erythrocyte Deformability 
Kikuchi et al. described a tool for measuring blood fluidity or blood rheology [18] in 1992, and this 
has subsequently been implemented in numerous studies [19-26]. Figure 6 shows a diagram of this 
tool, called a micro-channel array flow analyzer (MC-FAN). It includes a characteristic V-shaped 
groove array in an integral circuit, with 8,736 flow paths (width, 7 μm; length, 30 μm; depth, 4.5 μm) 
engraved  on  a  15  ×   15  ×   0.5-mm  single-crystal  silicon  substrate,  using  an  anisotropic  etching Sensors 2010, 10                                       
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technique. The array is housed in a cylinder. This equipment makes it possible to not only observe red 
cells  passing  through  individual  micro-channel  arrays  by  use  of  an  inverted  metallographic 
microscope, but also to evaluate blood fluidity through the groove array in terms of transit time of the 
blood sample for a given transit sample volume. Flow rate can be determined by timing when the 
blood sample meniscus crosses graduation marks at 10 μL intervals from 0–100 μL. Transit sample 
volume was therefore equivalent to loss of the blood sample within the cylinder. Here we review our in 
vitro  findings  on  blood  fluidity  during  mild  heating,  using  a  MC-FAN  (type-HR300;  Hitachi 
Haramachi Electronics Co., Ibaraki, Japan). 
Figure 6. External appearance (a) of a micro-channel array flow analyzer (MC-FAN) and 
diagram (b) of cylinder house. Blood samples were allowed to flow through the cylinder 
house by applying a pressure difference of 20 cm H2O (i.e., the difference between saline 
container and reservoir). 
 
 
Donors  were  male  or  female  student  volunteers  from  the  Prefectural  University  of  Hiroshima,  
aged 18–22 years. All volunteers were aware of the aims and procedures of the study and gave their 
informed consent to participate, as approved by our Institutional Ethical Review Board. Nine aliquots 
of freshly drawn venous blood samples (10 mL in total) were obtained from healthy donors and mixed 
with  one  aliquot  of  3.2%  sodium  citrate  (Na3C6H5O7  2H2O)  or  3.8%  sodium  citrate  (Na3C6H5O7 
5H2O). Blood samples were centrifuged at 400 g for 10 min at 0–4 ° C, to eliminate the possibility of 
interference with blood fluidity measurements caused by platelet aggregation onto micro-channel flow 
paths. The supernatant (platelet-rich plasma, PRP) was then discarded using a narrow Teflon-lined 
capillary connected to a water-jet pump. The remainder (PRP-removal blood) was subjected to mild 
heating, prior to application to the MC-FAN. A 2-ml aliquot was placed in a test tube and incubated in 
a  water  bath  maintained  at  each  desired  temperature  (±  0.1  °C )  above  37  ° C  for  30  min,  using 
NESLAB temperature control (Model RTE-100 or 111 or 210 or 221). Sensors 2010, 10                                       
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Figure 7. Microscopic details of blood samples passing through individual micro-channel 
array of the MC-FAN. (a) View of temperature-untreated sample with transit time = 12.6 s 
and  transit  sample  volume  =  25  μL. (b)  Identical  temperature-untreated  with  transit 
time = 27.8 s and transit sample volume = 50 μL. (c) View of identical blood sample to 
that in a and b, but subjected to mild heating at 45 °C  for 30 min prior to application to 
MC-FAN, with a transit time = 120.7 s and transit sample volume = 30 μL. 
 
 
Using a 1-mL disposable syringe and a thin catheter, 200 μL of each temperature-treated blood 
sample was introduced into a groove array via the cylinder house, which was connected to the inlet 
hole. The sample was allowed to flow through the cylinder house by applying a pressure difference  
of 20 cm H2O. Red cells passing through individual micro-channel arrays were monitored using an 
inverted  metallographic  microscope,  a  video-camera,  and  a  video-recorder  system.  As  shown  in  
Figure 7a and b, microscopic images revealed good erythrocyte deformability in temperature-untreated 
samples subjected to MC-FAN. However, a marked decline in erythrocyte deformability was observed 
in blood samples treated at temperatures above 37 ° C for 30 min. An example is shown in Figure 7c. 
Temperature-treated samples also demonstrated increased transit time for low transit sample volumes. 
Figure 8 illustrates some examples of blood fluidity of temperature-treated samples measured as transit 
time against transit sample volume. These graphs show that erythrocyte deformability decreased with 
increasing temperature over 37 ° C, although there was considerable inter-individual variation. 
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Figure 8. Representative examples (n = 4) of blood fluidity measured in terms of transit 
time against transit sample volume. Solid lines represent the temperature-untreated control; 
broken lines represent samples treated at 37 ° C; one-point lines represent samples treated  
at 42 ° C; and two-point lines represent samples treated at 45 ° C. 
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Figure 9. Blood fluidity in samples from six further donors measured in terms of transit 
time  against  transit  sample  volume.  Solid  lines  represent  the  temperature-untreated 
control; broken lines represent samples treated at 37 ° C; one-point lines represent samples 
treated at 42 ° C; and two-point lines represent samples treated at 45 ° C. 
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Table 1. Summary of the mean ±  standard deviation of transit time of blood samples (s) for 
a given transit sample volume (μL). Prior to application of MC-FAN, blood samples were 
subjected to mild heating at 37 °C , 42 °C  and 45 ° C for 30 min, respectively. The number 
of subjects was 10. Significant differences (p < 0.001) of the temperature-treated samples 
against the temperature-untreated reference were shown as **. 
The mean ±  standard deviation of transit time of blood samples (s) for a given 
transit sample volume (μl) 
 
Transit blood sample volume  (μL) 
 
20 μL  40 μL  60 μL 
Temperature-untreated reference 
 
8.0 ±  1.08  16.3 ±  2.24  25.1 ±  3.50 
Temperature-treated at 37°C  
 
7.8 ±  1.35  16.4 ±  2.57  26.4 ±  3.42 
Temperature-treated at 42° C 
 
8.5 ±  1.38**  18.3 ±  2.94**  36.3 ±  6.32** 
Temperature-treated at 45°C  
 
9.3 ±  2.46**  21.2 ±  5.99**  41.8 ±  13.23** 
 
Blood  was  therefore obtained from  further six healthy donors,  and temperature-treated samples 
were  compared  with  a  temperature-untreated  sample  as  a  reference  (Figure  9).  The  results  were  
similar  to  those  in  Figure  8.  Both  sets  of  results  (n  =  10)  are  summarized  in  Table  1.  The  
temperature-dependent decrease in erythrocyte deformability induced by mild heating was evaluated 
using  Student’s  t-test  on  the  total  sum  of  the  difference  in  transit  times  between  a  given  
temperature-treated  sample  and  each  temperature-untreated  reference,  with  varying  transit  sample 
volumes  (20,  40  and  60  μL).  Significant  differences  (p  <  0.001)  between  the  treated  and  control 
samples were evident for all samples treated at 45 °C  with transit sample volumes of 20, 40 and 60 μL 
and all samples treated at 42 °C  with transit sample volumes of 20, 40 and 60 μL. To cope with 
Figures 8 and 9, significant differences (p < 0.001) of the samples treated at 45°C  (i.e., two-point lines) 
and 42 °C  (i.e., one-point lines) against the control samples (i.e., solid lines) were shown, respectively. 
We therefore concluded that erythrocyte deformability decreased with increasing temperature of the 
blood sample over 37 °C . 
5. Discussion 
Hemichrome is rarely found in erythrocytes in situ. However, spectroscopic analysis has shown that 
human HbO2 A from healthy donors tends to degrade to hemichrome, even at close to physiological 
temperatures  and  pH.  However,  this  process  is  a  function  of  pH,  temperature  and  progress  of 
autoxidation of ferrous HbO2 A to ferric metHb, through oxidation by bound oxygen. The findings 
suggest  that  autoxidation  is  inseparably  related  to  the  instability  of  Hb  and  its  degradation  to 
hemichrome. 
As with autoxidation, Shikama [27-30] evaluated various mechanisms involving MbO2 and HbO2. 
Shikama clearly demonstrated that the autoxidation reaction does not simply involve the dissociative Sensors 2010, 10                                       
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loss of O2
- from HbO2, but is rather caused by the nucleophilic displacement of O2
- from HbO2 by a 
water molecule or a hydroxyl ion that enters the heme pocket from the surrounding solvent. The iron is 
thus converted to the ferric met form, and the water molecule or hydroxyl ion remains bound to Fe (III) 
at the sixth coordinate position to form the aqua- or hydroxide-met species. A generalized pathway for 
this SN2 mechanism can be written using monomeric Mb (MbO2) as an example: 
 
where  kA  represents  the  rate  constant  of  anion-induced  autoxidation  with  nucleophilic  anion 
displacement and N
- can be SCN
-,F
-,OCN
-, N3
-, or CN
-, and in vivo, H2O or OH
-. Here, anion-induced 
autoxidation with nucleophilic anion displacement of O2 results in an intermediate ferrous heme/anion 
complex that acts as an electron donor to displace oxygen. 
In the framework of this SN2 mechanism and the accepted framework of hemichrome formation [9], 
hemichrome can form in physiologically normal Hb molecules by the following scheme: 
 
where Hbsub represents each subunit of the Hb molecule. Nucleophilic displacement of O2
- by entry of 
a water molecule or a hydroxyl ion should be the rate-limiting step, and the subsequent conversion of 
the met form into hemichrome by a heme ligand (N
-) endogenous to the protein must proceed very 
quickly  with  the  kinetic  relationship  kN  >>  kA.  The  most  probable  candidate  for  N
-  in  the  HbA 
molecule is N
ε-nitrogen of the distal His (E7) (the only amino acid side chain in the ligand pocket) of 
each subunit, because N
ε-nitrogen is located more than 0.4 nm from the iron in Hb, and is therefore not 
expected to coordinate in native Hb [9]. 
It  is  significant  to  note  that  the  content  of  metHb  in  normal  red  cells  has  been  reported  to  
be ≤1% [31,32]. An NADH-dependent enzyme system can reduce metHb to deoxy-ferrous Hb and 
prevent the continued accumulation of metHb resulting from oxidation of the bound O2 to the ferrous 
heme  iron  (II)  [33-35].  This  fact  poses  the  question  of  how  erythrocytes  can  elicit  the  range  of 
responses to hemichrome with such a small amount of metHb. We suggest that this can be achieved by 
intramolecular anion-induced nucleophilic displacement of molecular dioxygen via an intermediate 
ferrous heme/anion complex (a low-spin hemichrome) [13]. Such a reaction would follow the scheme:  Sensors 2010, 10                                       
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In this scheme, nucleophilic displacement can be caused within the heme pocket by N
ε-nitrogen of 
the distal His (E7) instead of nucleophilic incursion of the water molecule or the hydroxyl ion from 
outside the molecule. As indicated earlier, hemichrome formation occurred at every stage during the 
autoxidation reaction of HbO2 A, i.e., at the initial, intermediate, and final stages, as a function of the 
pH and temperature of the solution. While the reaction proceeds along this scheme, it is possible that 
hemichromes can be derived not only from HbO2 species, but also from deoxy Hb and metHb. Thus, 
vital hemichromes in erythrocytes in situ might arise from intramolecular anion-induced nucleophilic 
displacement of O2 via an intermediate ferrous heme/anion complex. 
As aforementioned, Heinz bodies have been detected and characterized in drug-induced hemolytic 
anemia, defects in the intraerythrocytic reducing system (e.g., G-6-PD deficiency) and in unstable Hb 
disease [1,2]. Regarding the molecular pathogenesis of unstable Hb disease, the instability of labile Hb 
variants in patients can be attributed to amino acid substitutions (or deletions), which disrupt and 
perturb the Hb structure via interference with α-helix formation, disruption of heme binding, or altered 
α1β1  or  α2β2  contacts  [1].  The  consequent  changes  in  circulating  red  cells  in  patients  include:  an 
inherent tendency towards irreversible denaturation of Hb or globin due to a defect in the amino acid 
composition  of  the  labile  Hb  molecules;  a  continuous  tendency  toward  hemichrome  formation; 
precipitation or aggregation of the molecules resulting in building up of the molecules to form Heinz 
bodies; and hemolysis.  
Exposure of red cells to acetylphenylhydrazine and subsequent staining with crystal violet also 
revealed a greater abundance of Heinz bodies within G-6-PD deficient cells, compared with that in 
normal cells [36,37]. In addition, Sear et al. [38] and Campwala and Desforges [39] reported that 
Heinz bodies often appeared in normal aging red cells, and that this age-related appearance of Heinz 
bodies  was  especially  pronounced  in  splenectomized  individuals  [40].  According  to  several  
authors  [41-43],  aged  or  damaged  red  cells  affected  by  drugs  may  be  filtered  off  by  the  spleen, 
irrespective of whether or not they contain Heinz bodies, in a similar manner to the filtering off of red 
blood cells in patients with unstable Hb caused by unstable Hb hemolytic anemia. The number of 
Heinz bodies formed in normal erythrocytes from freshly drawn venous blood from healthy donors 
increased with increasing temperature; when aliquots of venous blood were subjected to mild heating 
at temperatures over 37 ° C for 30 min, Heinz bodies were visualized by exposing blood smears to 
acetylphenylhydrazine and staining with crystal violet. 
The combination of in situ observations and experimental findings suggests that instability leading 
to  hemichrome  formation  is  not  only  a  peculiarity  of  labile  Hb  variants,  but  is  also  an  innate 
characteristic of physiologically normal Hb molecules. Hemichrome formation and subsequent Heinz 
body clustering can occur in normal red cells as a consequence of cell aging, oxidative stress, or the 
effects of destabilizing factors, such as pH and temperature. Amino acid substitutions (or deletions) Sensors 2010, 10                                       
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characteristic of the Hb variants in unstable Hb disease [1], for instance, could reinforce the innate 
instability of normal Hb molecules. 
Figure  10  shows  a  diagram  of  the  proposed  biosensing  mechanisms  in  the  spleen  that  are 
responsible for the removal of aged and damaged red cells from the blood circulation. The suggested 
sequential  changes  occurring  within  normal  red  corpuscles  upon  the  removal  of  non-functional 
erythrocytes  include:  a  continuous  tendency  toward  hemichrome  formation;  precipitation  or 
aggregation of the molecules resulting in the formation of Heinz bodies; and hemolysis. To maintain 
senescent cell recognition or homeostasis in the blood circulation, Hb molecules might exert delicate 
control  of the fate of  erythrocytes via hemichrome formation  and  Heinz body  clustering, through 
promotion of the innate molecular instability of physiologically normal Hb resulting in the production 
of oxidized or denatured Hb. The distal His (E7) at position 64 in the α chain and at position 94 in the 
β chain of the Hb molecule might play a key role in hemichrome formation. Heinz body-containing red 
cells  become  trapped  in  the  spleen  while  traversing  small  apertures  in  the  basement  membranes 
separating the cords from the sinusoids [3], where the spaces are sufficiently small to require extreme 
deformation of red cells. We demonstrated that erythrocyte deformability decreased with increasing 
temperatures over 37 ° C. 
Figure 10. Diagram representing biosensing mechanisms in the spleen responsible for the 
removal of aged and damaged red cells from the blood circulation. 
 
Normal erythrocytes only develop Heinz bodies late in their lifespan. A wide variety of biochemical 
changes  have  been  reported  to  accompany  red  cell  aging  [44],  including  carboxymethylation  of 
proteins, activation of proteases, glycosylation of proteins, loss of membrane area, decline in changes 
in the band 4.1a to 4.1b ratio, increases in oxidized lipids and proteins, changes in cell rheology and 
fragility, changes in exposure of cell surface sugars, and gradual accumulation of Ca
2+.
 With regard to 
this issue, Low [45] demonstrated that band 3 clustering might warrant closer scrutiny as a possible 
transducer of distress signals from the cytoplasm to the external surface of the cell, in light of the fact 
that  it  can  be  caused  by  hemichrome  binding,  ATP  depletion,  malondialdehyde  formation,  Ca
2+ 
accumulation, oxidative cross-linking, or membrane skeletal weakening. It is known that hemichromes 
formed within erythrocytes bind to the cytoplasmic portion of band 3 in the membrane, then rapidly 
copolymerize  with  the  soluble  cytoplasmic  domain  of  membrane  band  3,  forming  an  insoluble 
copolymer, followed by other changes involved in the pathogenesis of red cell destruction [46-50]. The 
dominant  role  of  band  3  clustering  suggests  that  hemichrome  formation-induced  band  3  Sensors 2010, 10                                       
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clustering could also provide a key to the control of the fate of senescent and damaged red cells in the 
blood circulation. 
The mechanisms shown in Figure 10 not only help to explain the fate of normal erythrocytes in the 
blood circulation, but also shed light on some clinical aspects of hemolytic anemia and its associated 
acute blood loss. The situation in patients with G-6-PD deficiency [1,2] can be used as an example. 
Red cells are known to be vulnerable to injury by endogenous and exogenous oxidants. Oxidants can 
be  inactivated  by  reduced  glutathione  in  erythrocytes  with  normal  G-6-PD  activity,  because  the 
pentose phosphate shunt supplies NADPH, which is required for glutathione recycling. In G-6-PD 
deficient  erythrocytes,  however,  the  reduced  glutathione  cannot  be  restored  and  the  cells  sustain 
irreversible oxidative damage. However, G-6-PD deficiency only produces symptoms when the patient 
is exposed to an environmental factor that results in increased oxidative stress, including drugs such as 
antimalarials  (e.g.,  primaquine,  pamaquine,  dapsone),  sulfonamides,  nitrofurantoin  and  phenacetin. 
The resulting crisis can lead to hemolysis of up to 25–30% of the red cells within hours. However, the 
crisis is self-limited, and only the older population of red blood cells is destroyed. The mechanisms 
responsible for such an acute hemolytic crisis in patients taking these drugs cannot be explained on the 
basis  of  conventional  views.  However,  Figure  10  suggests  that  this  crisis  could  be  triggered  by 
fluctuations in endogenous and exogenous oxidative stress under the fragile pentose phosphate shunt. 
Malaria provides another example. This is a protozoal disease transmitted by the bite of female 
Anopheles mosquitoes (Plasmodium falciparum, P. malariae, P. vivax, and P. ovale). Blackwater fever 
syndrome is caused by infection with P. falciparum, and is characterized by repeated bouts of chills 
and fevers, severe intravascular hemolysis and anemia, jaundice, hemoglobinuria (black urine) and 
splenic enlargement [51-53]. Patients often develop fevers above 40 ° C. A feature of this disease is 
that the symptoms can be exacerbated in defected patients with G-6-PD deficiency as a result of taking 
quinine. In these patients, massive destruction of the red cells infected by the parasites occurs, but 
similar numbers of normal erythrocytes are also ruptured, resulting in characteristic hemoglobinuria. 
The reason for the massive hemolysis of non-infected red cells is unclear. However, the possibility of a 
relationship between quinine ingestion and the associated massive hemolysis, and the relevance of  
G-6-PD deficiency are addressed in Figure 10. Fever above 40° C, an endogenous G-6-PD deficiency, 
and exogenous quinine ingestion all represent conditions that induce acute hemolysis, thus leading to 
massive blood loss and hemoglobinuria. 
6. Conclusions 
(1)  This  overview  has  discussed  the  molecular  biosensing  mechanisms  in  the  spleen,  where 
hemichrome formation and subsequent Heinz body clustering within erythrocytes play key roles in the 
removal of aged and damaged red cells from the blood circulation. 
(2) Spectrophotometric evidence suggests that the autoxidation of Hb molecules was inseparably 
related to the instability of Hb and its degradation to hemichrome. 
(3) Based on the accepted SN2 mechanism for autoxidation of human HbO2 A and the accepted 
framework for hemichrome formation, we concluded that vital hemichromes in erythrocytes might 
arise from intramolecular anion-induced nucleophilic displacement of O2 via an intermediate ferrous 
heme/anion complex in physiologically normal Hb molecules. Sensors 2010, 10                                       
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(4) In this reaction scheme, the most probable candidate for such an intramolecular anion in normal 
Hb molecules is the N
ε-nitrogen of the distal His (E7), since N
ε-nitrogen is located more than 0.4 nm 
from the iron.  
(5)  Accordingly,  nucleophilic  displacement  could  be  caused  within  the  heme  pocket  by  the  
N
ε-nitrogen of the distal His (E7) of the Hb molecule, instead of nucleophilic incursion of a water 
molecule or hydroxyl ion from outside the molecule. 
(6) Thus, the N
ε-nitrogen of the distal His (E7) at position 64 of the α chain and position 94 of the β 
chain can delicately control the fate of red blood corpuscles through the removal of non-functional 
erythrocytes  from  the  circulation  by  causing  hemichrome  formation  and  subsequent  Heinz  body 
clustering. The rigid intraerythrocytic hemichrome inclusions act as “sticking points” in the spleen, and 
hence Heinz body-containing red cells become trapped and undergo hemolysis. 
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